Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae

Mitsuo Narita1, Hiroshi Tanaka, Takehiro Togashi

  • 1Department of Pediatrics, Sapporo Tetsudo (JR) Hospital, Sapporo, Japan.

Pediatric Neurology
|August 10, 2005
PubMed

Insights

Mycoplasma pneumoniae infections can affect the central nervous system via immune responses. Elevated levels of interleukin-6, interleukin-8, and interleukin-18 in cerebrospinal fluid suggest their involvement in these neurological manifestations.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Mycoplasma pneumoniae can cause central nervous system (CNS) manifestations.
  • The exact mechanism involves the host immune response rather than direct neural damage or toxins.
  • Understanding the inflammatory markers is crucial for diagnosing and managing these neurological complications.

Purpose of the Study:

  • To measure serum and cerebrospinal fluid (CSF) levels of specific cytokines in patients with M. pneumoniae-associated CNS manifestations.
  • To investigate the role of interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-18 (IL-18), interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and transforming growth factor-beta1 (TGF-β1) in the pathogenesis.
  • To differentiate the cytokine profiles across various CNS manifestation types.

Main Methods:

  • Analysis of serum and CSF samples from patients diagnosed with M. pneumoniae infection and CNS manifestations.
  • Categorization of patients into early-onset encephalitis, late-onset encephalitis, encephalitis without fever, and aseptic meningitis groups.
  • Quantification of cytokine levels using appropriate laboratory assays.

Main Results:

  • Intrathecal elevations of IL-6 and IL-8 were detected in all four types of CNS manifestations.
  • Elevated IL-18 levels were specifically observed in patients with late-onset encephalitis.
  • IFN-γ, TNF-α, and TGF-β1 were not detectable in any of the CSF samples.

Conclusions:

  • IL-6, IL-8, and IL-18 are implicated in the inflammatory processes underlying CNS manifestations of M. pneumoniae infection.
  • These cytokines may serve as potential biomarkers for diagnosing and understanding the neuroinflammatory response.
  • The findings highlight the role of specific immune mediators in M. pneumoniae-induced neurological disease.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...